grace capital boosted its holdings in Colgate-Palmolive (NYSE:CL) by 177.8% in the 4th quarter, Holdings Channel reports. The firm owned 2,500 shares of the company’s stock after purchasing an additional 1,600 shares during the period. grace capital’s holdings in Colgate-Palmolive were worth $149,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also added to or reduced their stakes in the stock. Janus Henderson Group PLC raised its position in Colgate-Palmolive by 16.6% during the 3rd quarter. Janus Henderson Group PLC now owns 461,370 shares of the company’s stock worth $30,888,000 after buying an additional 65,628 shares during the last quarter. Bank of New York Mellon Corp raised its position in Colgate-Palmolive by 1.1% during the 3rd quarter. Bank of New York Mellon Corp now owns 20,359,199 shares of the company’s stock worth $1,363,050,000 after buying an additional 223,814 shares during the last quarter. Ontario Teachers Pension Plan Board raised its position in Colgate-Palmolive by 9.3% during the 3rd quarter. Ontario Teachers Pension Plan Board now owns 25,381 shares of the company’s stock worth $1,699,000 after buying an additional 2,170 shares during the last quarter. Korea Investment CORP raised its position in Colgate-Palmolive by 64.1% during the 3rd quarter. Korea Investment CORP now owns 664,239 shares of the company’s stock worth $44,471,000 after buying an additional 259,399 shares during the last quarter. Finally, Quantbot Technologies LP purchased a new position in Colgate-Palmolive during the 3rd quarter worth $3,351,000. Hedge funds and other institutional investors own 76.12% of the company’s stock.

CL has been the subject of a number of analyst reports. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a research report on Thursday, January 10th. Morgan Stanley set a $62.00 price objective on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research report on Tuesday, January 29th. BNP Paribas upgraded shares of Colgate-Palmolive from an “underperform” rating to a “neutral” rating and upped their price objective for the stock from $56.00 to $67.00 in a research report on Monday, February 11th. Wells Fargo & Co restated a “hold” rating and set a $57.00 price objective on shares of Colgate-Palmolive in a research report on Friday, January 25th. Finally, Jefferies Financial Group restated a “hold” rating and set a $61.00 price objective on shares of Colgate-Palmolive in a research report on Friday, February 1st. Three investment analysts have rated the stock with a sell rating, twelve have given a hold rating and four have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $65.47.

In other news, CEO Ian M. Cook sold 16,000 shares of the company’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $66.72, for a total transaction of $1,067,520.00. Following the transaction, the chief executive officer now directly owns 1,146,793 shares of the company’s stock, valued at approximately $76,514,028.96. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Ian M. Cook sold 22,634 shares of the company’s stock in a transaction on Tuesday, February 19th. The stock was sold at an average price of $66.31, for a total transaction of $1,500,860.54. Following the transaction, the chief executive officer now directly owns 1,162,793 shares in the company, valued at $77,104,803.83. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 67,700 shares of company stock worth $4,486,804. Corporate insiders own 1.02% of the company’s stock.

NYSE:CL opened at $66.92 on Wednesday. The company has a debt-to-equity ratio of 32.25, a quick ratio of 0.76 and a current ratio of 1.14. Colgate-Palmolive has a fifty-two week low of $57.41 and a fifty-two week high of $72.61. The firm has a market cap of $57.66 billion, a PE ratio of 22.53, a P/E/G ratio of 4.28 and a beta of 0.78.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 25th. The company reported $0.74 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a net margin of 15.44% and a return on equity of 25,268.29%. The business had revenue of $3.81 billion for the quarter, compared to analysts’ expectations of $3.78 billion. During the same period in the prior year, the company posted $0.75 EPS. The business’s revenue for the quarter was down 2.1% on a year-over-year basis. As a group, equities research analysts expect that Colgate-Palmolive will post 2.83 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a dividend of $0.43 per share. The ex-dividend date is Wednesday, April 17th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.57%. Colgate-Palmolive’s dividend payout ratio is 56.57%.

TRADEMARK VIOLATION NOTICE: This news story was first reported by Watch List News and is the property of of Watch List News. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://www.watchlistnews.com/grace-capital-grows-position-in-colgate-palmolive-cl/2921740.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

See Also: How is Preferred Stock Different from Common Stock?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.